Current Take on Systemic Sclerosis Patients' Vaccination Recommendations
- PMID: 34960174
- PMCID: PMC8708328
- DOI: 10.3390/vaccines9121426
Current Take on Systemic Sclerosis Patients' Vaccination Recommendations
Abstract
Systemic sclerosis (SSc) is a rare autoimmune inflammatory rheumatic disease. The prevalence of SSc ranges from 7 to 700 cases per million worldwide. Due to multiple organ involvement and constant inflammatory state, this group of patients presents an increased risk of infectious diseases. This paper aimed to gather the up-to-date evidence on vaccination strategies for patients with SSc and to be a useful tool for the prevention and management of infectious diseases. The authors conducted a scoping review in which each paragraph presents data on a specific vaccine's safety, immunogenicity, and efficacy. The work deals with the following topics: SARS-CoV-2, seasonal influenza, S. pneumoniae, HAV, HBV, HZV, N. meningitidis, H. influenzae, HPV, and diphtheria-tetanus-pertussis.
Keywords: H. influenzae; HPV; HZV; N. meningitidis; S. pneumoniae; SARS-CoV-2; diphtheria-tetanus-pertussis; hepatitis; influenza; systemic sclerosis.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Elhai M., Avouac J., Walker U., Matucci-Cerinic M., Riemekasten G., Airò P., Hachulla E., Valentini G., Carreira P., Cozzi F., et al. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study. Ann. Rheum. Dis. 2016;75:163–169. doi: 10.1136/annrheumdis-2014-206386. - DOI - PubMed
-
- Khedoe P., Marges E., Hiemstra P., Ninaber M., Geelhoed M. Interstitial Lung Disease in Patients with Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) Front. Immunol. 2020;11:19090. doi: 10.3389/fimmu.2020.01990. - DOI - PMC - PubMed
-
- Nagaraja V., Matucci-Cerinic M., Furst D.E., Kuwana M., Allanore Y., Denton C.P., Raghu G., McLaughlin V., Rao P.S., Seibold J.R., et al. Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis. Arthritis Rheumatol. 2020;72:1049–1058. doi: 10.1002/art.41246. - DOI - PMC - PubMed
-
- Barahona-Correa J.E., De la Hoz A., López M.J., Garzón J., Allanore Y., Quintana-López G. Infections and systemic sclerosis: An emerging challenge. Rev. Colomb. Reumatol. 2020;27:62–84. doi: 10.1016/j.rcreue.2019.12.004. - DOI
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous